TABLE 2.
Oligo- nucleotide | Sequencea |
---|---|
RB1 | 5′-TGCTCGAGCAGCAACGCCTACTTAG-3′ |
RB2 | 5′-TGCTCGAGATATTTGTGCGCTATTGAGACTC-3′ |
RB3 | 5′-TGCTCGAGTATGAGGCAAATGGATTAGAG-3′ |
RB4 | 5′-TGCTCGAGGCGGTCGCTTAGATGT-3′ |
RB5 | 5′-GCTGATGGTTATGGTCTAGCGAATG-3′ |
RB6 | 5′-TGCGGTGTAGTCATGGCTGTTACT-3′ |
F1 | 5′-TGCTCGAGTACGGTTCGATTGGCTATTTGAG-3′ |
F2 | 5′-TGCTCGAGCTTTAAGCGGGTAATGTGATTGA-3′ |
F3 | 5′-TTGGCGCGCCTGAGCCTAACCAACCCAACCACA-3′ |
F4 | 5′-TTGGCGCGCCTGAGGACTGCCAATCATAATGTT-3′ |
F5 | 5′-GGCACTGGCGTCGTCTATC-3′ |
F6 | 5′-TTTGTTGCGGTATTGAAATTGAAC-3′ |
F7 | 5′-TTGGCGCGCCAAGCGTTGGGTGGCATCACTTAG-3′ |
A2 | 5′-TGCTCGAGAAGATACCGCCGTTAGTTTC-3′ |
A4 | 5′-TTGGCGCGCCAGTGTCGCATTTATTGGCAGA-3′ |
A7 | 5′-TGGGCGCGCCATCCAGAATCAGGCAATAGCATT-3′ |
K1 | 5′-ATTGCGATCGATTTATGCTTGTAAACCGTT-3′ |
AK1 | 5′-TTGGCGCGCCTTATGCTTGTAAACCGTT-3′ |
The underlined regions indicate the following restriction endonuclease sites engineered into the oligonucleotides: XhoI sites in RB1, RB2, RB3, RB4, F1, F2, and A2; AscI sites in F3, F4, F7, A7, and AK1; and a ClaI site in K1.